Skip to main content
MiniMed Group, Inc. (MMED)
NASDAQ: MMED · Real-Time Price · USD
17.99
+0.11 (0.64%)
At close: Nov 13, 2026, 4:00 PM EST
16.99
-1.00 (-5.53%)
After-hours: Nov 13, 2026, 7:30 PM EST

MiniMed Group Financials Overview

Millions USD. Fiscal year is May - Apr.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023
Period EndingJul '26 Apr '26 Apr '25 Apr '24 Apr '23
Revenue
3,2223,1022,7152,4692,245
Revenue Growth
15.65%14.25%9.96%9.98%-
Gross Profit
1,8331,7701,5281,4381,316
Operating Income
12812233-53-61
Net Income
-314-333-213-112-96
Earnings Per Share
-1.19-1.30-0.84-0.44-
EPS Growth
-----

Revenue by Segment
Chart
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023
Period EndingJul '26 Apr '26 Apr '25 Apr '24 Apr '23
Pumps
560546541540477
Consumables
983956854777760
Continuous Glucose Monitoring (CGM)
1,6011,5531,3131,117958
Other Segment
494663450
Revenue (Total)
3,2223,1022,7152,4692,245

Cash & Debt
Chart
Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023
Period EndingJul '26 Apr '26 Apr '25 Apr '24 Apr '23
Cash & Investments
207298115458
Total Debt
5953674930
Net Cash (Debt)
148245-56528
Net Cash Growth
----82.14%-
Net Cash Per Share
0.560.95-0.220.02-

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023
Period EndingJul '26 Apr '26 Apr '25 Apr '24 Apr '23
Operating Cash Flow
-105-19714041-6
Capital Expenditures
-211-223-193-148-167
Free Cash Flow
-316-420-53-107-173
Free Cash Flow Growth
-----

Margins
Chart
Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023
Period EndingJul '26 Apr '26 Apr '25 Apr '24 Apr '23
Gross Margin
56.89%57.06%56.28%58.24%58.62%
Operating Margin
3.97%3.93%1.21%-2.15%-2.72%
Pretax Margin
-5.34%-6.09%-5.38%-2.79%-3.34%
Profit Margin
-9.74%-10.73%-7.85%-4.54%-4.28%
FCF Margin
-9.81%-13.54%-1.95%-4.33%-7.71%

Valuation
Chart
Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023
Period EndingNov '26 Apr '26 Apr '25 Apr '24 Apr '23
Forward PE
29.7343.29---
PS Ratio
1.571.20---